Mouse BAFF/BLyS/TNFSF13B Antibody, R&D Systems™

BAFF/BLyS/TNFSF13B

Immunocytochemistry 8-25 μg/mL

Monoclonal

Rat

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.

ApoL related ligand TALL-1, B lymphocyte stimulator, BAFFB-cell activating factor, B-cell-activating factor, BLyS, BLYSB-lymphocyte stimulator, CD257, CD257 antigen, Dendritic cell-derived TNF-like molecule, DTL, TALL1, TALL-1delta BAFF, TALL1Delta4 BAFF, THANK, TNF and ApoL-related leukocyte expressed ligand 1, TNF- and APOL-related leukocyte expressed ligand 1, TNF homolog that activates apoptosis, TNFSF13B, TNFSF20, tumor necrosis factor (ligand) superfamily, member 13b, tumor necrosis factor (ligand) superfamily, member 20, tumor necrosis factor ligand superfamily member 13B, tumor necrosis factor superfamily, member 13b, tumor necrosis factor-like protein ZTNF4, ZTNF4

Mouse myeloma cell line NS0-derived recombinant mouse BAFF/BLyS/TNFSF13B, Ala127-Leu309, Accession # Q9WU72

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects mouse BAFF/BLyS/TNFSF13B in direct ELISAs.

121834

Immunocytochemistry

Unconjugated

Mouse

Q9WU72

10673

IgG2a

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.